
Oragenics (OGEN) Earnings Dates & Reports
Oragenics (OGEN) Most Recent Earnings
Report DateMay 12, 2023
Period EndingQ1 2023
Est. EPS-$3
Actual EPS-$1.41
EarningsBeat
Oragenics (OGEN) Earnings
View the latest Oragenics (OGEN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Oragenics (OGEN)
Order type
Buy in
Order amount
Est. shares
0 shares
Oragenics (OGEN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Oragenics (OGEN) Latest Earnings
The value each OGEN share was expected to gain vs. the value each share gained.
Oragenics (OGEN) reported its most recent earnings on May 12, 2023 for Q1 2023, posting earnings per share (EPS) of -$1.41. This exceeded analysts' expectations of -$3 by 53.00%, marking a Beat.
For comparison, Oragenics reported EPS of -$3 in the same quarter last year.
The company is expected to announce its next earnings report on 08/08/2025, with analysts projecting an EPS of $0.
Oragenics (OGEN) Earnings History
Oragenics (OGEN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Oragenics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 9, 2025 | — | — | — |
Mar 14, 2025 | — | — | — |
Nov 13, 2024 | — | — | — |
Aug 9, 2024 | — | — | — |
Oragenics (OGEN) Earnings FAQs
Oragenics (OGEN) last reported earnings on May 12, 2023 for Q1 2023, posting an EPS of -$1.41, which Beat the estimate of -$3 by 53.00%.
For Q1 2023, Oragenics (OGEN) reported an EPS of -$1.41, exceeding analysts' estimate of -$3 by 53.00%.
For Q1 2023, Oragenics (OGEN) Beat expectations with an actual EPS of -$1.41 vs. an estimated EPS of -$3.
Following the last earnings report on May 12, 2023, Oragenics (OGEN)'s stock price moved — from — to —.
The next Oragenics (OGEN) earnings call is scheduled for Aug. 8, 2025, where executives will discuss financial results and outlook.